Philippe Musette

Bobigny, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.

Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.

Journal: JAMA dermatology

Published: March 05, 2025

Bridging the gap in autism care: A qualitative analysis of policies, practices, and family experiences.

Bridging the gap in autism care: A qualitative analysis of policies, practices, and family experiences.

Journal: Public health

Published: March 04, 2025

Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.

Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.

Journal: JAMA dermatology

Published: January 24, 2024

Variability of viral reactivations during recurrence of DRESS.

Variability of viral reactivations during recurrence of DRESS.

Journal: The Australasian journal of dermatology

Published: August 01, 2022

Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.

Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.

Journal: Frontiers in immunology

Published: April 07, 2022

Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Journal: Frontiers in molecular biosciences

Published: November 03, 2021

Updated French guidelines for the therapeutic management of bullous pemphigoid.

Updated French guidelines for the therapeutic management of bullous pemphigoid.

Journal: Annales de dermatologie et de venereologie

Published: March 18, 2021

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen.

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen.

Journal: Frontiers in immunology

Published: February 09, 2021

Clinical and biological activity of rituximab in the treatment of pemphigus.

Clinical and biological activity of rituximab in the treatment of pemphigus.

Journal: Immunotherapy

Published: October 13, 2020

Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Author Correction: B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid.

Journal: Scientific reports

Published: December 10, 2019

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Journal: The British journal of dermatology

Published: August 29, 2019

Editorial: Skin Blistering Diseases.

Editorial: Skin Blistering Diseases.

Journal: Frontiers in medicine

Published: February 21, 2019

Showing 1-12 of 34

Last Updated: 09/26/2026